Who We Are
A Canadian specialty medical device and pharmaceutical company pioneering drug-device combination technologies.
About Our Organization
Angiotech Pharmaceuticals is a Canadian specialty medical device and pharmaceutical company that focuses on technologies for implantable medical devices, surgery, and targeted drug delivery. We became widely known for pioneering the combination of pharmaceuticals with medical devices — particularly through drug-coated stent technology.
Our research emphasizes reducing complications associated with implanted medical devices, surgical procedures, and acute injuries by combining pharmaceuticals with innovative device designs. We develop technologies spanning interventional oncology, wound closure, ophthalmology, and the biomaterials used in medical implants.
Our most influential contribution is work on paclitaxel-coated medical devices, helping establish the concept of drug-eluting devices in cardiovascular medicine and influencing later generations of combination medical technologies.
Our Mission
To improve patient outcomes by integrating pharmaceuticals with medical devices — reducing the complications that limit the effectiveness of implants, surgery, and interventional procedures.
Our Values
Integration
We combine pharmaceuticals with devices instead of treating them as separate disciplines.
Science
Rigorous chemistry, materials, and clinical science shape every program we advance.
Depth
Two decades of platform R&D across biomaterials and controlled drug elution.
Collaboration
We build alongside device OEMs, clinicians, and academic partners.